Schedule 13G ownership disclosure

Agios Pharmaceuticals Inc

Security class unavailable · CUSIP: 00847X104

Event date: 2016-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,205,223
Percent of class
10.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562230-17-000001
Form type
SC 13G/A
Filer
AGIOS PHARMACEUTICALS, INC.
CIK
CIK 1439222
Filed
Jan 09, 2017
Reporting period
Dec 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub